Prognostic Role of KRAS G12C Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

KRAS G12C mutation (mKRAS G12C) is the most frequent KRAS point mutation in non-small cell lung cancer (NSCLC) and has been proven to be a predictive biomarker for direct KRAS G12C inhibitors in advanced solid cancers. We sought to determine the prognostic significance of mKRAS G12C in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wankhede, Durgesh, Bontoux, Christophe, Grover, Sandeep, Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572143/
https://www.ncbi.nlm.nih.gov/pubmed/37835787
http://dx.doi.org/10.3390/diagnostics13193043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572143/
https://www.ncbi.nlm.nih.gov/pubmed/37835787
http://dx.doi.org/10.3390/diagnostics13193043

Ejemplares similares